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In Vitro Models of Carcinogenesis:
Expression of Recessive Genes by
Chromosomal Mutations
By John B. Little*
There has beenconsiderable recent interest in the mechanisms bywhich recessive mutations involvingcancer
genes may be expressed. We have developed an in vitro model to study this phenomenon in an endogenous
autosomal gene in human cells. We have analyzed the molecular structural changes that lead to loss ofhet-
erozygosity at the thymidine kinase (tk) locus. The results indicate that expression ofa recessive allele fre-
quently occurs by loss ofheterozygosity atthat locus. Over90% ofspontaneous mutants atthe tk locus arose
byallele loss. Thefraction ofinducedmutantsthatarosebythismechanismdependeduponthe inducingagent.
Loss ofthe active tk allele was often accompanied by loss oflinked genetic loci on the longarm ofchromo-
some 17. These results suggest that large-scale chromosomal mutations resulting from events such as dele-
tion or mitotic recombination may be an important mechanism for the expression ofactivated or mutated
recessive genes in human cells. Such recessive mutations could involve oncogenes or other growth regula-
tory genes important in carcinogenesis.
It gives me great pleasure to participate in this Sym-
posium that celebrates the 40th Anniversary ofthe Insti-
tute ofEnvironmental Medicine and honors itsleaderfor
many ofthose years, Norton Nelson. I have been associ-
ated with the Environmental Health Center at Harvard
for the past 25 years, and we have always felt a special
relationship with ourmanyfriends at New York Univer-
sity. Jim Whittenberger was the founder and leader for
many years of our Center. He and Norton Nelson are
close personal friends as well as scientific colleagues, who
together share amajorresponsibility forthe development
ofthe field ofenvironmental health as we know it today.
Introduction
It has long been recognized that the development ofa
malignant tumor in vivo is a complex, multistage process
that likely involves genetic and epigenetic events. With
the development ofcellular systemsthat allowus to study
the neoplastic transformation ofindividual cells in vitro,
ithasbecome evident thatthisinitial stage intheprocess
ofcarcinogenesis is also acomplex one(1,2). Studies in hu-
man and rodent cells indicate that at least two cellular
processes are involved. The first is morphological trans-
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formation orthe conversion ofnormal cells to those with
the malignant phenotype in terms of their growth and
cytologic characteristics. The second is immortalization
orthe development ofa cell line with anunlimitedpoten-
tial forproliferation. Immortalization has proven difficult
to induce inhuman cells, perhapsbecause oftheirkaryo-
typic stability (3).
It appears likely that heritable mutational changes in
target cell DNA are involved in neoplastic cell transfor-
mation, though the precise role ofsuch mutations is not
yet clear. In some cases, they appearto be involved in the
initiation of carcinogenesis and in others at subsequent
stages. Balmain(4), forexample, presented evidence that
activation ofthe ras oncogene by specificbase mutations
is animportantmechanismfortheinitiation ofmouse skin
tumors by various chemical carcinogens. Cerutti (5) em-
phasized the potential importance ofchromosomal muta-
tions in the process ofcarcinogenesis. Chromosomal mu-
tations result from large-scale changes including
translocations, rearrangements ordeletions, ratherthan
point mutations such as those associated with ras gene
activation (4). X-radiation, for example, is an efficient in-
ducerofstablechromosomalrearrangements(6), andfully
transformed, immortalized human cells in vitro are
characteristically aneuploid with multiple chromosomal
abnormalities (7).
There has been considerable recent interest in the loss
of heterozygosity by such chromosomal mutations as a
mechanism for the expression ofrecessive mutations inJ. B. LITTLE
cancer genes. This hypothesis has beengiven impetus by
the findingthat certain hereditary tumors are character-
ized by loss of heterozygosity at specific chromosomal
sites; retinoblastoma, for example, is associated with a lo-
cus on chromosome 13 (8,9). A model we have developed
to study this phenomenon invitro (10)will be described;
in particular, to analyze the molecular structure of chro-
mosomal changes associated with the loss ofheterozygos-
ity at an autosomal locus in human cells.
Methodology
The detailed methodology and results ofthese experi-
ments are described elsewhere (10,11). The characteris-
tics ofthe humanlymphoblastoid cell line designated TK6
are shown inTable 1 (12). Ofparticular note isthefactthat
these cells are heterozygotic at the thymidine kinase (tk)
locus. They contain two copies ofthe tk gene in their na-
tive locations on chromosome 17, but one of these has
been inactivated by a frameshift mutagen. We thus study
the induction of changes in the chromosome containing
the active gene that lead to expression of the inactive
gene, yielding the tk-/- phenotype.
Molecular structural changes atthe active tkallele were
examined by restriction enzyme mapping on Southern
blots hybridized to a full-length cDNA tk probe. The ac-
tive allele was identified by means of a Sacd restriction
fragment length polymorphism (RFLP) located within
the tk gene. By analyzing changes in the polymorphic
SacI band, as well as the restriction patterns for four
other enzymes, the structural changes in mutant clones
could be separated into three categories (10). The first is
characterized by no change in the restriction patterns, in-
dicating that the mutant phenotype arose from a point
mutation (or more specifically, a change involving less
than 200 base pairs). Loss of the polymorphic band, as-
sociated with no other change in restriction patterns, in-
dicates that loss of heterozygosity resulted from loss of
the entire active tk allele. The appearance of new bands
indicates that an intragenic rearrangement had occurred.
Molecular Structural Changes
Leading to Loss of Heterozygosity
The distribution ofthe structural changes amongst over
200 mutant clones arisingeither spontaneously orfollow-
ing treatment with four different classes ofmutagens are
shown in Table 2. As can be seen, loss ofheterozygosity
Table 1. Characteristics ofTK6 human lymphoblastoid cell line.
Near diploid, stable karyotype with serial sub-cultivation
Immortal
Rapid growth in suspension
High cloning efficiency, measured in 96-well microtiter dishes
Single X chromosome (XY)
Thymidine kinase heterozygote (TK + ), one active and one nonactive
but unrearranged tk gene both in native locations on chromosome 17
Table 2. Molecular structural changes leading to loss of
heterozygosity at the tk locus in 218 mutant clones.
Inducing Number Structural changes at active tk locus
agent analyzed No change Rearranged Loss (%)
Spontaneous 51 10 5 36 (71)
X-irradiation 56 18 3 35 (63)
UV light 20 10 1 9 (43)
Mitomycin C 67 45 4 18 (27)
EMS 24 20 2 2 (8)
in approximately two-thirds ofspontaneously arising and
x-ray induced mutant clones resulted from loss ofthe en-
tire active gene. This fraction was lower for UV light or
mitomycin-C induced mutants. None ofthe ethylmethane
sulfonate (EMS)mutantswere apparentlyassociatedwith
loss ofthe entire allele. The lowfraction ofmutant clones
in this category (8%) were probably spontaneously aris-
ing; the induced frequency of mutations in the EMS
treated cultures was only 6-fold above background (as
comparedwith 10-foldforthe othermutagens) such that
3 ofthe 24 mutants scored should be spontaneous ones.
Mostoftheremainingmutantcloneswere associatedwith
no change in the restriction patterns, indicating that a
small scale change or point mutation had occurred.
In the course ofthese experiments, it became evident
that a second class ofslow growing mutants occurred at
the tk locus (11). These mutant colonies arose after 20
days ofincubation in selective medium, whereas normal
growth mutants were scored after 12 days. When these
slowgrowthmutants were isolated and serially subculti-
vated invitro, slowgrowth rate remained a stable pheno-
typic characteristic over many cell doublings. The mean
cell doublingtime was approximately 34 hr(range21-44)
among slow growth mutants as compared with 16 hr
(range 14-18) in normal growth mutants. When 100 dif-
ferent clones were analyzed, the range ofdoublingtimes
was highly distinct for each ofthe two types ofmutants
with no overlap (Liber, Yandell, and Little, unpublished
data).
The distribution ofthe molecular structural changes as-
sociated with over 200 slow growth mutant clones are
shown in Table 3. In contradistinction to the results for
normal growth clones (Table 2), loss ofheterozygosity in
slowgrowth mutant clones was associated almostentirely
withlossofthe entire activegene. This was trueforEMS-
induced mutants as well as those that arose spontane-
ously or were induced by X-rays or mitomycin-C. These
results suggestthat slowgrowthmutants arise as the re-
sult ofa separate and distinct class ofmutational events.
The relative size of the slow growth mutant fraction
Table 3. Molecular structural changes leading to loss of
heterozygosity at the tk locus in 203 slow growth mutant clones.
Inducing Number Structural changes at active tk locus
agent analyzed No change Rearranged Loss (%)
Spontaneous 120 4 1 115 (96)
X-irradiation 22 1 1 20 (91)
Mitomycin C 37 1 0 36 (97)
EMS 24 2 0 22 (92)
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varied with each mutagen, ranging from approximately
30% of all mutations for EMS to 80% for X-rays. About
one-half of spontaneously arising mutant clones were of
the slow-growth type.
There are several different mechanisms by which loss
ofheterozygosity at the tklocus on chromosome 17 could
occur. These include loss ofthe active allele through non-
disjunction (with or without reduplication ofthe chromo-
some containingthe inactivegene), mitoticrecombination,
or gene conversion. These are mechanisms that are
presumably not available at X-linked orhemizygous loci.
Loss of the active gene could also occur as a result of a
deletion or a point mutation.
Extent of Large-Scale Changes
Leading to Loss of Heterozygosity
To approach the question ofwhich ofthese mechanisms
may be operating in our in vitro system, we have esti-
mated the extent of the structural changes associated
with the loss ofthe active gene in mutant clones by ex-
aminingpolymorphic markers located elsewhere on chro-
mosome 17. These include a Xhol polymorphism within
the erb Al gene located proximal to tk on the long arm
of chromosome 17, and a PstI polymorphism within the
sequencerecognized bythe D17S2probepresumably lo-
cated on the short arm of chromosome 17. Analysis of
changes at these loci allow us to determine whetherloss
ofthe active tkallele in mutant clones extends to involve
a proximal locus on the long arm of chromosome 17, or
may in addition involve loss of a short arm marker sug-
gesting that nondisjunction had occurred.
The results ofexperiments in which changes at the erb
Al locus were examined in tkmutant clones arisingfrom
loss ofthe active gene are shown in Table 4. About one-
third ofnormal growth mutants and 50% ofslow-growth
mutants showing loss ofthe tk gene also showed loss of
the erb Al gene on the same chromosome. The fraction
showingloss oferb Al did not differ significantly among
spontaneously arising mutants and those induced by
three different mutagens. These results suggest that loss
of heterozygosity at the tk locus is associated in many
cases with a large scale change on the long arm ofchro-
mosome 17involving anothergenetic locus some distance
away.
On the otherhand, inonly 5 ofmore than300tkmutant
clones analyzed was loss ofthe short armmarkerrevealed
Table 4. Structural changes at the erb AI locus in 190 tk mutant
clones showing loss of active tk gene.
Structural changes
Mutant Inducing Number erb AI
phenotype agent analyzed No change Loss
Normal growth Spontaneous 28 17 11
X-irradiation 18 11 7
UV light 6 4 2
Mitomycin C 12 9 3
Slow growth Spontaneous 95 45 50
Mitomycin C 31 17 14
aData from Yandell et al. (11).
bythe D17S2 probe observed. Thisfinding suggests that
nondisjunction is a relatively rare cause ofloss ofheter-
ozygosity at the tk locus. In a preliminary analysis of
cytogenetic changes associated with these tk mutants,
karyotyping has been carried out in 18 spontaneously
arisingmutant clones. Both copiesofchromosome 17were
present in all clones; in 16 ofthe 18, chromosome 17 was
karyotypically normal. Presumptive evidence for very
small deletions involving the longarm ofchromosome 17
were found in the other two. These preliminary results
suggest that multi-locus changes asidentifiedby molecu-
lar structural analyses are not usually associated with
cytogenetically detectible deletions or rearrangements.
Conclusions
These results indicate thatlarge-scale chromosomal mu-
tations resulting from events such as deletion or mitotic
recombination may indeed be an important mechanism
for the expression of recessive mutations in cells. Such
recessive mutations could involve oncogenes or other
growth regulatory genes important in neoplastic trans-
formation. This phenomenon could, for example, repre-
sent a mechanism by which a mutant gene is expressed
in the later stages ofcarcinogenesis; itiswell knownthat
the appearance ofmultiple chromosomal abnormalities is
associated with the later stages of transformation and
tumorigenesis. The occurrence ofsuch chromosomal mu-
tations would thus facilitate the expression ofrecessive
cancer genes that have been mutated either at the time
ofthe initial exposure to the carcinogen or have been car-
ried as a germ-line mutation as in hereditary retinob-
lastoma.
Finally, the system described offers a useful model for
studying this phenomenon invitro. We are currently iden-
tifying othermarkers in and near the tkgene in order to
better map the extent and type ofmolecular changes in-
volved. Ofparticular interest is the question ofwhether
mitotic recombination is an important mutational mech-
anism at anendogenous gene in itsnormalposition in the
human genome.
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